Pantoprazolo Git (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazolo Git, is a Proton Pump Inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazolo Git as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazolo Git belongs to the proton pump inhibitor class and is indicated for conditions involving excess gastric acid secretion. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis. - Erosive peptic ulcer disease: accelerates ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumours.

Pantoprazolo Git may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea or abdominal discomfort. - Flatulence or bloating. - Constipation: occasional. - Dry mouth.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile‑associated diarrhoea. - Acute interstitial nephritis. - Low magnesium levels (hypomagnesemia). - Fracture risk with long‑term use. - Liver enzyme elevations.

When prescribing Pantoprazolo Git, clinicians should consider patient‑specific factors and monitor for potential complications. - Renal impairment: adjust monitoring, no dose change required. - Hepatic impairment: use with caution, monitor liver function. - Elderly patients: assess fracture risk with prolonged therapy. - Concomitant use of NSAIDs or steroids: increase ulcer risk, monitor closely. - Pregnancy and lactation: only if clearly needed, evaluate risk‑benefit. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Pantoprazolo Git can affect the absorption or metabolism of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal exposure. - Atazanavir: markedly decreased antiviral levels.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR. - Methotrexate (high dose): reduced clearance, monitor toxicity. - Digoxin: slight increase in serum concentration. - Clopidogrel: possible reduction in antiplatelet effect. - Iron supplements: decreased iron absorption, separate dosing by ≥2 h.